Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Joseph A. Awad"'
Publikováno v:
Surgical Practice. 27:23-26
Autor:
Ahmed Osama Hassan, Yasmine Hany Hegab, Joseph Ri Awad, Yasser A. Orban, Abd-Elrahman M. Metwalli
Publikováno v:
International Journal of Surgery Case Reports
Highlights • The diagnosis and management of cases with acute biliary pancreatitis. • Minimally invasive techniques gave encouraging results with minimal complications. • Cholecystectomy is recommended to prevent the recurrence of acute gallsto
Autor:
Jonathan N. Menachem, Ashish S. Shah, Matthew R. Danter, Sandip Zalawadiya, Kelly Schlendorf, JoAnn Lindenfeld, Joseph A. Awad, Roman E. Perri, Suzanne Brown Sacks, H. O'Dell, C. Darragh, L. Punnoose, R. Fowler, D. Marshall Brinkley, Mark Wigger, Keki R. Balsara, H. Ooi, S. Smith, Shelly Ruzevich-Scholl
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 66(5)
Donor-derived hepatitis C (dd-HCV) infection may increase the risk of renal impairment (RI) among heart transplantation (HT) recipients. Sofosbuvir, an integral component of HCV direct-acting antivirals (DAAs) has also been linked to RI. To date, no
Autor:
H. Ooi, Sandip Zalawadiya, Joseph A. Awad, Matthew R. Danter, D. Marshall Brinkley, Mark Wigger, Roman E. Perri, S. Ruzevich-Scholl, Ashish S. Shah, Jonathan N. Menachem, JoAnn Lindenfeld, H. O'Dell, Cori Edmonds, Keki R. Balsara, L. Punnoose, Christopher Schwartz, Alicia Carver, Kelly Schlendorf, Emily Sandhaus, Suzanne Brown Sacks
Publikováno v:
JAMA Cardiol
Importance For patients awaiting heart transplant, hepatitis C–positive donors offer an opportunity to expand the donor pool, shorten wait times, and decrease wait-list mortality. While early reported outcomes among few heart transplant recipients
Autor:
Derek W. Cool, Joseph A. Awad, Jessica R. Rodgers, Derek J. Gillies, Chandima Edirisinghe, Nirmal Kakani, Aaron Fenster
Publikováno v:
Medical physics. 46(6)
Purpose Minimally invasive procedures, such as microwave ablation, are becoming first-line treatment options for early-stage liver cancer due to lower complication rates and shorter recovery times than conventional surgical techniques. Although these
Autor:
H. O'Dell, J. K. Wright, L. Gorden, Andrew Scanga, S. Karp, A. Rafferty, S. Alexopoulos, S. Geevarghese, L. Matsuoka, Joseph A. Awad, N. Schneider, R. Perri
Publikováno v:
Journal of Hepatology. 70:e565-e566
Autor:
Chan Y. Chung, JoAnn Lindenfeld, Roman E. Perri, Mark Wigger, Joseph A. Awad, Matthew R. Danter, Ashish S. Shah, C. Rueda Rios, Jonathan N. Menachem, S. Smith, H. O'Dell, C. Darragh, S. Ruzevich-Scholl, Kelly Schlendorf, H. Ooi, Rachel M. Hayes, M. Brinkley, Sandip Zalawadiya, Mary E. Keebler, S.B. Sacks
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:S196-S197
Autor:
H. Ooi, L. Punnoose, Roman E. Perri, S. Ruzevich-Scholl, Keki R. Balsara, Ashish S. Shah, H. O'Dell, M. Brinkley, S. Brown Sacks, Mark Wigger, Sandip Zalawadiya, R. Fowler, Kelly Schlendorf, JoAnn Lindenfeld, Lynne W. Stevenson, Joseph A. Awad, Jonathan N. Menachem, Matthew R. Danter
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S48
Purpose The shortage of suitable donors for heart transplantation (HT) contributes to wait-list mortality and increased reliance on mechanical circulatory support. Since the advent of direct-acting antivirals (DAA) for treatment of hepatitis C (HCV),
Autor:
Mark Wigger, H. Ooi, Matthew R. Danter, S. Smith, S. Ruzevich-Scholl, H. O'Dell, C. Darragh, D.M. Brinkley, Jonathan N. Menachem, Sandip Zalawadiya, Ashish S. Shah, Roman E. Perri, Joseph A. Awad, L. Punnoose, JoAnn Lindenfeld, R. Fowler, Keki R. Balsara, S. Brown Sacks, Kelly Schlendorf
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S49
Purpose Donor-derived hepatitis C infection (dd-HCV) infection may increase risk of renal impairment (RI) among heart transplant (HT) recipients. Sofosbuvir, an integral component of anti-HCV direct-acting antivirals (DAAs), has also been linked to R
Autor:
H. Ooi, L. Punnoose, JoAnn Lindenfeld, S. Ruzevich-Scholl, S. Negrotto, D.M. Brinkley, Sandip Zalawadiya, Joseph A. Awad, Mark Wigger, Roman E. Perri, H. O'Dell, C. Darragh, Jonathan N. Menachem, Matthew R. Danter, Keki R. Balsara, Elias V. Haddad, Ashish S. Shah, S. Brown Sacks, Kelly Schlendorf, R. Fowler, S. Smith
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S281
Purpose Prior to the advent of direct-acting antivirals (DAAs), donor-derived hepatitis C (dd-HCV) viremia predicted poor post-heart transplant (HT) outcomes, including a higher risk of coronary allograft vasculopathy (CAV) and death. Considering the